SenesTech, Inc. - Common Stock (NQ:SNES)

0.8409 +0.0619 (+7.95%)

Delayed Quote Updated: 2:45 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about SenesTech, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

SenesTech (SNES) Q2 2026 Earnings Call Transcript ↗

August 12, 2026

E-commerce revenue surged 186% sequentially as management pivots to direct sales.

Via The Motley Fool

Topics Earnings

SenesTech (NASDAQ:SNES) Beats Q2 Revenue and EPS Estimates, Yet Shares Dip 6% After Hours ↗

August 05, 2026

Via Chartmill

SenesTech SNES Q1 2026 Earnings Call Transcript ↗

May 14, 2026

SenesTech SNES Q1 2026 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

SenesTech Inc (NASDAQ:SNES) Q1 EPS Beat Drives After-Hours Stock Surge Despite Revenue Miss ↗

May 12, 2026

Via Chartmill

Earnings Scheduled For November 10, 2025 ↗

November 10, 2025

Via Benzinga

Uncovering Potential: SenesTech's Earnings Preview ↗

November 07, 2025

Via Benzinga

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

SenesTech (SNES) Q4 2025 Earnings Call Transcript ↗

March 12, 2026

SenesTech (SNES) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 11, 2025

Via Benzinga

SenesTech Inc (NASDAQ:SNES) Reports Mixed Q3 2025 Results with Record Revenue but Stock Decline ↗

November 10, 2025

SenesTech Q3 2025: Record revenue & strong product growth, but stock fell after a revenue miss. EPS beat estimates, showing improved cost control.

Via Chartmill

12 Health Care Stocks Moving In Friday's After-Market Session ↗

August 08, 2025

Via Benzinga

SenesTech (SNES) Q2 Sales Jump 36% ↗

August 07, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 01, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 13, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

April 24, 2025

Via Benzinga

SenesTech's Big Play On Small Pests ↗

April 17, 2025

Via Talk Markets

Topics Stocks / Equities

SenesTech CEO Reveals Surprise San Francisco Expansion ↗

April 16, 2025

A discussion about the $4B rodent control market and the company’s game-changing product Evolve – a revolutionary form of rodent birth control.

Via Talk Markets

Topics Stocks / Equities

SenesTech: A Little-Known Biotech Company Worthy Of Attention ↗

April 01, 2025

SenesTech, an under-the-radar biotech company with a focus on solving the global pest population problem through, humane fertility control measures, seems attractively valued.

Via Talk Markets

Topics Stocks / Equities

Why Rubrik Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket ↗

March 14, 2025

Via Benzinga

SenesTech CEO Interview: Breaking Down Record Earnings & The Road To Profitability ↗

March 13, 2025

With no direct competition in the fertility control space and growing demand for non-lethal rodent management, could SNES be the next big winner? Find out in this deep-dive conversation with CEO Joel...

Via Talk Markets

Topics Stocks / Equities

Why Intel Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket ↗

March 13, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 12, 2025

Via Benzinga

SenesTech's Financing Move: $1.1 Million From Warrant Exercise, New Deals Loom ↗

March 10, 2025

SenesTech shares lower as they exercise outstanding warrants for 374,718 shares at reduced price, plans to use proceeds for corporate purposes.

Via Benzinga

Earnings Scheduled For March 12, 2025 ↗

March 12, 2025

Via Benzinga

SenesTech: The Smart Money’s Bet On Rodent Population Control ↗

March 05, 2025

SenesTech is a small company with an innovative way for rodent control using induced infertility. They have rapidly expanded with pilot programs in major US cities and also globally in New Zealand and...

Via Talk Markets

Topics Stocks / Equities

SenesTech Has Built A Better Mouse Trap ↗

February 19, 2025

SenesTech's Evolve products are recent, but take a novel approach to rodent plagues, painlessly reducing reproduction velocity and the product is already taking off with huge distribution deals in...

Via Talk Markets

Topics Stocks / Equities

SenesTech Expands Rapidly With Evolve, Poised For Breakout Growth In 2025 ↗

February 14, 2025

SenesTech, a disruptive biotech firm, is quietly making major strides in municipal adoption, international expansion, and retail penetration.

Via Talk Markets

Topics Stocks / Equities

SenesTech Expands Rapidly With Evolve, Poised For Breakout Growth In 2025 ↗

February 13, 2025

SenesTech is disrupting rodent control with Evolve, a fertility-based solution gaining traction in NYC & Baltimore.

Via Talk Markets

Topics Stocks / Equities

TechMediaBreaks – SenesTech Inc. (NASDAQ: SNES) Reports 51% Revenue Increase in Q3 2024, Highlights Growth in Evolve Product Line and International Expansion

December 02, 2024

Via Investor Brand Network

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.